| Product Code: ETC10738349 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iran Orphan Drug Market Overview |
3.1 Iran Country Macro Economic Indicators |
3.2 Iran Orphan Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Iran Orphan Drug Market - Industry Life Cycle |
3.4 Iran Orphan Drug Market - Porter's Five Forces |
3.5 Iran Orphan Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Iran Orphan Drug Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 Iran Orphan Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Iran Orphan Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Iran Orphan Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of rare diseases in Iran |
4.2.2 Increasing government support and initiatives for orphan drug development |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in Iran |
4.3 Market Restraints |
4.3.1 High cost of orphan drugs leading to affordability issues for patients |
4.3.2 Limited awareness and education among healthcare professionals and patients about orphan drugs |
5 Iran Orphan Drug Market Trends |
6 Iran Orphan Drug Market, By Types |
6.1 Iran Orphan Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Iran Orphan Drug Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Iran Orphan Drug Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.4 Iran Orphan Drug Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.1.5 Iran Orphan Drug Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.6 Iran Orphan Drug Market Revenues & Volume, By Cell Therapy, 2021 - 2031F |
6.1.7 Iran Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Iran Orphan Drug Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 Iran Orphan Drug Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 Iran Orphan Drug Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.2.4 Iran Orphan Drug Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.2.5 Iran Orphan Drug Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.2.6 Iran Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Iran Orphan Drug Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Iran Orphan Drug Market Revenues & Volume, By Prescription Drugs, 2021 - 2031F |
6.3.3 Iran Orphan Drug Market Revenues & Volume, By Over-the-Counter, 2021 - 2031F |
6.3.4 Iran Orphan Drug Market Revenues & Volume, By Specialty Drugs, 2021 - 2031F |
6.3.5 Iran Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.3.6 Iran Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Iran Orphan Drug Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Iran Orphan Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Iran Orphan Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Iran Orphan Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Iran Orphan Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.6 Iran Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
7 Iran Orphan Drug Market Import-Export Trade Statistics |
7.1 Iran Orphan Drug Market Export to Major Countries |
7.2 Iran Orphan Drug Market Imports from Major Countries |
8 Iran Orphan Drug Market Key Performance Indicators |
8.1 Number of orphan drug clinical trials conducted in Iran |
8.2 Percentage increase in orphan drug approvals by Iranian regulatory authorities |
8.3 Patient enrollment rates in orphan drug access programs |
9 Iran Orphan Drug Market - Opportunity Assessment |
9.1 Iran Orphan Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Iran Orphan Drug Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 Iran Orphan Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Iran Orphan Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Iran Orphan Drug Market - Competitive Landscape |
10.1 Iran Orphan Drug Market Revenue Share, By Companies, 2024 |
10.2 Iran Orphan Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here